Human placenta drugs to require health registration.

Published: 2006-01-18 07:00:00

Updated: 2006-01-18 07:00:00

A human placenta drug has been produced by a product report system but will be controlled under the health registration requirements like other new drugs, drugs subjected to assess its efficacy and safety and bio drugs.

The KFDA disclosed a revised bill of "Designation of drugs to report" on ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK